Somatostatin (Sms) and its agonist analogues inhibit the secretory activities of endocrine and neural cells. Recent studies have suggested that Sms has significant immunomodulatory properties. In this study, we examined the effects of two Sms octapeptide analogues on the inflammatory reaction in vivo. BIM 23014 (Somatulin) and Sandostatin were administered to male Sprague-Dawley rats subject to carrageenin-induced aseptic inflammation, at doses of 2-10 ,ug/rat, given either systemically or locally. Animals were killed 7 h after the induction of the inflammation, and the inflammatory exudates were aspirated and quantitated in terms of volume and leukocyte concentration. Sms analogues, administered via either route, significantly reduced the volume and the leukocyte concentration of the exudate in a time-and dose-dependent fashion. In corroboration of these, immunohistochemical evaluation of the levels of local inflammatory mediators, such as immunoreactive (Ir) TNF-a, Irsubstance P, and Ircorticotropin-releasing hormone, was inhibited significantly by Sms analogue treatment. These findings suggest that Sms analogues have significant antiinflammatory effects in vivo, associated with suppression of proinflammatory cytokines and neuropeptides. Furthermore, these data suggest that Sms agonists may be useful in the control of inflammatory reaction. (J. Clin. Invest. 1994. 93
Introduction
Somatostatin (Sms)' and its analogues exert inhibitory actions on the secretory activities of neurons and neuroendocrine cells ( 1, 2) . In the dorsal root ganglia, a distinct population of neurons with small dark perikarya and unmyelinated axons is rich in Sms (3). The latter is transported from these sites to peripheral sensory nerve terminals, from which it is released in response to noxious stimuli (2) , involved thus in the axon reflex to local injurious stimuli. In addition, Sms is present in the spinal cord and the substantia gelatinosa (4) , both areas in-volved in transmission ofnociception (5) . Sms analogues exert analgesic effects when administered systemically, locally, epidurally, or intrathecally (6) (7) (8) (9) (10) . It has been proposed that many of the actions of Sms released from the peripheral nervous system are in opposition to those of substance P (sP), a major mediator of pain and neurogenic inflammation ( 11) .
Receptors for Sms have been identified on mononuclear leukocytes (12) and on T lymphocytes (13) . Sms suppresses endotoxin-induced leukocytosis, release of colony-stimulating activity by splenic lymphocytes, and immunoglobulin synthesis (14) . Sms and sP exert opposite effects upon T lymphocytes, respectively inhibiting and stimulating their activity ( 15, 16) . A decrease of peripheral lymphocyte number and function were reported in a patient with a somatostatinoma, as well as in normal controls given (17) . These findings suggested that Sms may have immunoregulatory properties and that it might act as an antiinflammatory agent.
The purpose of this study was to examine the potential antiinflammatory actions of two Sms analogues ( 18, 19) in vivo in an established rat model of acute inflammation. In addition to examining gross indices of the inflammatory response, such as volume and cellularity of the inflammatory exudate, the local presence of immunoreactive (Ir) Sms and the ability of Sms analogues to modify the local expression of known mediators of inflammation, such as TNF-a (20), sP (21 ) , and corticotropin-releasing hormone (CRH) (22) 
Induction ofsubcutaneous carrageenin inflammation
Experimental inflammation was induced by injection ofcarrageenin in previously generated subcutaneous (sc) air pouches in the intrascapular area ofthe rats as described by Tsurufuji (23) and modified slightly by us (24) . 4 ml of 2% carrageenin solution in normal saline was injected into the 24-h previously formed sc air pouch. The animals were killed 7 h after the carrageenin administration, the time ofpeak inflam-mation, and the exudates were aspirated and evaluated in terms of volume and leukocyte concentration. The leukocytes in the inflammatory exudate were mainly PMNs attracted to the local inflammatory site from the general circulation (25) .
Experimental protocol
Rats were divided in groups ofeight and given carrageenin and concomitantly either an intraperitoneal (i.p./systemic administration) or an intrapouch (local administration) injection of 1 ml of either BIM 23014 or Sandostatin solutions in 0.9% NaCl at increasing doses (0-10 ,gg/rat). Tissue preparation Pieces of inflammatory granuloma from the pouch were dissected en bloc with the surrounding tissues immediately after killing. These tissue specimens were fixed in 10% formalin and embedded in paraffin.
Immunohistochemistry
Peptide antisera production and purification. Polyclonal antisera against Sms (GC-27), r/hCRH (TS-2), TNF-a, and sP were produced in rabbits, as described previously (22, 26) . Before use they were affinity-purified by adsorption to synthetic Sms 1-14, r/hCRH 1-41, TNFa, and sP, respectively, coupled to cyanogen bromide-activated Sepharose 4B. Briefly, the antisera were added to the Sms-, r/hCRH-, TNFa-and sP-Sepharose 4B conjugates (1 mg of Sms 1-14, r/hCRH 1-41, TNF-a, or sP on 200 gg gel), respectively, and incubated at room temperature for 2 h. These suspensions were packed in 4 x 0.7-cm columns and washed with phosphate buffer (20 mM sodium phosphate, 0.5 M sodium chloride, pH 7.3) until the OD280 returned to baseline. The elutions obtained from these washings were depleted of anti-Sms, anti-r/hCRH, anti-TNF-a, and anti-sP IgG, respectively. The antibodies bound to the affinity columns (affinity-positive IgG fractions) were eluted with thiocyanate buffer (3 M potassium thiocyanate, 0.5 M ammonium hydroxide) and dialyzed against several changes of PBS.
Immunohistochemistry. Tissue specimens were preserved in 10% formalin. They were embedded in paraffin and sectioned onto gelatincoated microscope slides at a thickness of 6 jm. Immunoperoxidase staining was performed with the Vectastain ABC kit using the manufacturer's suggested protocol and reagents (27, 28) . All subsequent procedures took place at room temperature. The sections were deparaffinized with two 5-min washes in xylene and rehydrated by sequential rinses in absolute, 90%, 80%, and 70% ethanol. Endogenous peroxidase activity was exhausted by incubation with 0.3% peroxide in methanol for 45 min. The sections were then incubated sequentially with 0.1% BSA in PBS for 20 min and with diluted goat serum (1:66.7) for 20 min, and in a humid chamber with the affinity-purified rabbit antibody to r/hCRH (50 jg/ml anti-Sms, anti-r/hCRH, anti-TNF-a, or antisP), the control, affinity-negative IgG fraction (50 jg/ml), or nonimmune normal rabbit IgG (50 gg/ml). After 40 min, the sections were washed with PBS and incubated with biotinylated goat anti-rabbit IgG for 30 min. The sections were washed further with PBS and incubated with avidin and a biotinylated horseradish peroxidase complex for 45 min. Finally, the sections were washed, and color was developed by immersing sections in a solution of 0.05% wt/vol 3,3-diaminobenzidine tetrahydrochloride, 0.04% wt/vol nickel chloride, and 0.01% hydrogen peroxide in 0.05 M Tris, pH 7.4, for 2 min. The sections were counterstained with 0.5% light green SF. Positive staining was revealed as black to dark green spots, whereas light green color was seen in Sms-, r/hCRH-, TNF-a-, and sP-free areas, affinity-negative control sections, and nonimmune normal rabbit IgG control sections. The intensity and concentration of the specific staining on the tissue specimens were graded by two masked observers on a 0-4+ scale.
Statistical analysis
All results are expressed as mean±SEM. ANOVA followed by Fischer's least significant difference test was performed. Differences were considered significant when P < 0.05.
Results
Immunohistochemical detection ofIrSms in sc carrageenin-induced inflammatory granulomas. The presence of IrSms in sc carrageenin-induced inflammatory areas was examined immunohistochemically on tissue sections obtained from the inflammatory areas at the peak ofthe inflammatory reaction, 7 h after the injection of carrageenin. IrSms was detected in the cytoplasm of all three types of accessory cells, i.e., macrophages, tissue fibroblasts, and vascular endothelial cells (Fig. 1) 10 animals from each group were killed 2, 5, and finally 7 h after the induction of the inflammation. The degree of the inflammatory reaction was evaluated as described above (Fig. 4) . Both the volume and the leukocyte concentration of the exudate increased with time, reaching a zenith at 7 h in the control group. In the Sms analogue-treated group, both the volume and the leukocyte concentration were significantly lower than those of the control group. chemical pain stimuli (31 ) . We clearly detected IrSms in the carrageenin-induced inflammatory granulomas. This finding could reflect local release of Sms by sensory fibers C and/or postganglionic sympathetic neurons (2, 4, 30) , as part of the active inflammatory process. The positively stained accessory cells, cannot be excluded as additional sources ofthe Sms present in the inflammatory sites, but could also reflect uptake of neuronal Sms by these cells. The carrageenin-induced subcutaneous aseptic inflammation was suppressed by BIM 23014 in a dose-dependent fashion, whereas the Sandostatin inhibition of inflammation had no apparent dose-response effect at the dose range used. Use of additional dosages of Sandostatin would probably reveal a sigmoidal relationship between dose and effect. Of the two independent parameters of the inflammatory reaction measured, i.e., the volume of the exudate and the leukocyte concentration, the latter was more dramatically suppressed than the former by either analogue. This suggests that Sms exerts preferential effects on the inhibition of the migration of circulating leukocytes to the inflammatory site (predominantly PMN in the inflammatory exudates in our study) rather than on the suppression of the permeability of the capillary endothelium, which normally increases during inflammation. Blockade of the expression ofadhesion molecules and/or their receptors by endothelial cells and/or leukocytes and/or inhibition ofsecretion of chemotactic substances, such as IL-8, components of the complement system, or leukotrienes, could explain the preferential effects of Sms on leukocyte migration. These findings agree with in vitro data showing inhibition ofsP-induced PMN chemotaxis by Sandostatin (32) and with the previously observed Sms-induced suppression of impulse transmission of spinal cord neurons excited by noxious stimuli or local iontophoresis of sP. Furthermore, they agree with the fact that Sms analogues inhibit TNF-a release by LPS-stimulated macrophages (33) and with our data from this study demonstrating that Sms analogues gradually attenuate the secretion and/or activity ofinflammatory molecules, such as TNF-a, a cytokine (20), sP, a tachykinin (21 ) , and CRH, a local proinflammatory neuropeptide (22) , from the beginning of the inflammatory process to its 7-h peak in this model.
The antiinflammatory effect of both Sms analogues used was achieved after both systemic and local administration, suggesting that effective drug concentrations were reached at the site of inflammation regardless of the route of administration. The antiinflammatory effect observed after local administration was less than that after systemic administration. This might be because of additional effects of the latter at a wider area of regulation of the inflammatory reaction, including perhaps the dorsal root ganglia and the spinal cord (34) . Increased local enzymatic degradation ofSandostatin might also account for the decreased potency of this analogue, when administered locally, on the inflammatory exudate volume. Regardless of the route of administration, both Sms analogues resulted in similar antiinflammatory activities, as reflected by suppression of leukocyte concentration, suggesting that their potency in suppressing inflammation is parallel to their ability to suppress growth hormone secretion (35) . These data suggest that Sms agonists given systemically or applied locally might be useful in the control of inflammatory or autoimmune states.
The inflammatory cytokines TNF-a, IL-I#3, and IL-6 activate the hypothalamic-pituitary-adrenal axis by primarily causing hypothalamic CRH secretion, which leads to glucocorticoid secretion through ACTH release (36-39). Glucocorticoid secretion then limits the inflammatory reaction by preventing leukocytes from reaching the inflammatory site and by decreasing the secretion and action of various cytokines and lipid mediators of inflammation (25, 40) . It is not known whether Sms participates in such a physiologic process as an antiinflammatory peptide, and it would be ofinterest to examine the local secretion of Sms during glucocorticoid-induced suppression of the inflammatory response. In a preliminary report, dexamethasone was shown to inhibit all proinflammatory agents examined in the carrageenin model of inflammation, including TNF-a, CRH, and sP, while it allowed large, gradual increases of local IrSms over the 7-h assay (41 ) . This suggests that Sms may participate in the physiologic control of inflammation, in addition to glucocorticoids.
